This is a new report on the global market for Oncology IT published in June 2021.
The report evaluates and answers key market questions such as:
- How quickly is the convergence of EMR/OIS systems occurring and in which markets?
- Is the competitive make-up of the oncology IT market changing and which vendor types will be successful?
- How will the growth of AI/analytics-based capabilities unfold for oncology?
- What influence is enterprise imaging/tumour board adoption having on the oncology IT market, and how quickly will this market expand?
- Identify the products and end-markets driving growth
- Review the market drivers and barriers for growth
- Quantitative analysis of market size and forecast growth
- Market share estimates for the leading vendors
- Detailed profiles of selected vendors, with SWOT analysis for each
- Identify potential partners and acquisition targets
- Market analysis for Oncology Diagnostics, Companion Diagnostics, Decision Support Software and Care Management Platforms
- Impact of advanced machine learning and deep learning
- Influence of next generation DNA sequencing and processing technologies
- Review go-to-market strategies
- Analysis and insights to support your strategy and business planning
- Product pricing and software delivery strategies